Stocks

Acadia Pharmaceuticals ACAD

Health care sectorNasdaq

What to see in Acadia Pharmaceuticals now

Is Wall Street adding or cutting?+9

352 13F filers hold it · +9 against the quarter before · shares held +2.2%

Holdings of 06/30
Who bought more than 5%?5.3%

State Street holds 5.3%

Filed 08/07
What comes next?10/13 (Tue)

10/13 estimated earnings

Due 10/13

Company

Exchange
Nasdaq
Industry
Pharmaceutical Preparations
Headquarters
San Diego, California
Fiscal year end
12/31
Next earnings
10/13, estimated
  • 352 13F filers hold it · +9 against the quarter before · shares held +2.2%Holdings of 06/30
  • State Street holds 5.3%Filed 08/07

Funds

13F filers: 352 · +9 since the quarter before · 06/30 holdings

Famous funds that held Acadia Pharmaceuticals in their latest 13F report.

FundValueSince the quarter before
Mirae Asset Global ETFS HoldingsAcadia Pharmaceuticals ACAD · 06/30 holdings$2.1MNo quarter before
Bridgewater AssociatesAcadia Pharmaceuticals ACAD · 06/30 holdings$1.3MTrimmed −64.6%
Mirae Asset Global InvestmentsAcadia Pharmaceuticals ACAD · 06/30 holdings$193.7KTrimmed −13.9%
All tracked funds

5% stakes

Holder
State Street08/075.3%9,076,212 shFirst report
Vanguard Portfolio Management04/285.15%8,781,007 shFirst report
Baker Bros. Advisors02/2625.4%43,294,373 shNo earlier report
RTW Investments25/11/144.2%7,144,524 sh−1.0pp
All 5% stake reports on Acadia Pharmaceuticals

26-week trading